Related references
Note: Only part of the references are listed.Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda
Marcial Sebode et al.
LIVER INTERNATIONAL (2018)
Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine
Erik Munnig-Schmidt et al.
INFLAMMATORY BOWEL DISEASES (2018)
Early prediction of thiopurine-induced hepatotoxicity in inflammatory bowel disease
D. R. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites
Melissa A. Sheiko et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases
Aurelie Chapdelaine et al.
CLINICAL RHEUMATOLOGY (2017)
Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review
Shivani Deswal et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2017)
TPMT Testing Before Starting Azathioprine or Mercaptopurine: Surely Just Do It?
Jeremy D. Sanderson
GASTROENTEROLOGY (2015)
Update 2014: Advances to Optimize 6-Mercaptopurine and Azathioprine to Reduce Toxicity and Improve Efficacy in the Management of IBD
Jaimin Amin et al.
INFLAMMATORY BOWEL DISEASES (2015)
EASL Clinical Practice Guidelines: Autoimmune hepatitis
JOURNAL OF HEPATOLOGY (2015)
Optimizing the use of thiopurines in inflammatory bowel disease
Rishi M. Goel et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Thiopurine Metabolite Ratios for Monitoring Therapy in Pediatric Crohn Disease
U. Kopylov et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis
Y. S. de Boer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Use of a xanthine oxidase inhibitor in autoimmune hepatitis
Safa Al-Shamma et al.
HEPATOLOGY (2013)
Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease
N. A. Kennedy et al.
INTERNAL MEDICINE JOURNAL (2013)
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis
Harpreet K. Dhaliwal et al.
HEPATOLOGY (2012)
Treatment adherence - Room for improvement, not only in autoimmune hepatitis
Christina Weiler-Normann et al.
JOURNAL OF HEPATOLOGY (2012)
Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
Tiphaine Adam de Beaumais et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Azathioprine metabolite measurements are not useful for following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people
Elizabeth D. Ferucci et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease
Kara Bradford et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis
Ulf Hindorf et al.
JOURNAL OF HEPATOLOGY (2010)
Monitoring of Azathioprine Metabolites in Pediatric Patients With Autoimmune Hepatitis
Thi-Mai-Hoang Nguyen et al.
THERAPEUTIC DRUG MONITORING (2010)
Simplified criteria for the diagnosis of autoimmune hepatitis
Elke M. Hennes et al.
HEPATOLOGY (2008)
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
U. Hindorf et al.
GUT (2006)
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis
Michael A. Heneghan et al.
JOURNAL OF HEPATOLOGY (2006)
Thiopurine methyltransferase screening before azathioprine therapy
V Gauba et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis
Albert J. Czaja et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
Selective inhibition of inflammatory gene expression in activated T lymphocytes: A mechanism of immune suppression by thiopurines
CW Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis
PG Langley et al.
JOURNAL OF HEPATOLOGY (2002)
Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: A preliminary report
C Rumbo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Current and novel immunosuppressive therapy for autoimmune hepatitis
MA Heneghan et al.
HEPATOLOGY (2002)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Share Paper
